|
⚲
|
| Keyboard |
| Irani Zackary S
✚
|
|
|---|---|
| CIK # | 0001282349 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 4 | [0001282349] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Biomerica Inc | |
| Irani Zackary S |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Biomerica Inc BMRA
Common stock
|
2025-12-12 | Grant | 52,500 | $0.00 | |
|
Biomerica Inc BMRA
Common stock
|
2024-12-13 | Grant | 250,000 | $0.31 | 77,500 |
|
Biomerica Inc BMRA
Non-qualified stock option · derivative
|
2023-12-13 | Grant | 155,000 | ||
|
Biomerica Inc BMRA
Common Stock
|
2023-05-25 | Buy | 200 | $1.55 | 310 |
|
Biomerica Inc BMRA
Common Stock
|
2023-05-24 | Buy | 500 | $1.61 | 805 |
|
Biomerica Inc BMRA
Common Stock
|
2023-05-12 | Buy | 1,700 | $1.17 | 1,989 |
|
Biomerica Inc BMRA
Common Stock
|
2023-05-10 | Buy | 500 | $1.27 | 635 |
|
Biomerica Inc BMRA
Common Stock
|
2023-05-09 | Buy | 300 | $1.39 | 417 |
|
Biomerica Inc BMRA
Common Stock
|
2023-05-04 | Buy | 1,000 | $1.36 | 1,360 |
|
Biomerica Inc BMRA
Common Stock
|
2023-04-28 | Buy | 1,800 | $1.34 | 2,412 |
|
Biomerica Inc BMRA
Common Stock
|
2023-04-27 | Buy | 2,600 | $1.31 | 3,406 |
|
Biomerica Inc BMRA
Common Stock
|
2023-04-26 | Buy | 7,000 | $1.26 | 8,820 |
|
Biomerica Inc BMRA
Non-qualified stock option · derivative
|
2023-04-20 | Grant | 105,000 | ||
|
Biomerica Inc BMRA
Common Stock
|
2023-01-25 | Buy | 1,800 | $2.85 | 5,130 |
|
Biomerica Inc BMRA
Common Stock
|
2023-01-24 | Buy | 2,000 | $2.81 | 5,620 |
|
Biomerica Inc BMRA
Non-qualified stock option · derivative
|
2021-12-09 | Grant | 100,000 | ||
|
Biomerica Inc BMRA
Non-qualified stock option · derivative
|
2020-12-10 | Grant | 78,616 | ||
|
Biomerica Inc BMRA
Common Stock
|
2020-02-28 | Other | 78,431 | $2.85 | 223,528 |
|
Biomerica Inc BMRA
Non Qualified Stock Option · derivative
|
2019-12-19 | Grant | 125,000 | ||
|
Biomerica Inc BMRA
Common Stock
|
2018-12-21 | Other | 600 | $2.04 | 1,224 |
| showing 20 of 81 most recent transactions | |||||